Swerdlow Russell H
University of Kansas Alzheimer's Disease Research Center, Fairway, KS, USA.
Departments of Neurology, Molecular and Integrative Physiology, and Biochemistry and Molecular Biology, University of Kansas School of Medicine, Kansas City, KS, USA.
J Alzheimers Dis. 2023;92(3):751-768. doi: 10.3233/JAD-221286.
Viable Alzheimer's disease (AD) hypotheses must account for its age-dependence; commonality; association with amyloid precursor protein, tau, and apolipoprotein E biology; connection with vascular, inflammation, and insulin signaling changes; and systemic features. Mitochondria and parameters influenced by mitochondria could link these diverse characteristics. Mitochondrial biology can initiate changes in pathways tied to AD and mediate the dysfunction that produces the clinical phenotype. For these reasons, conceptualizing a mitochondrial cascade hypothesis is a straightforward process and data accumulating over decades argue the validity of its principles. Alternative AD hypotheses may yet account for its mitochondria-related phenomena, but absent this happening a primary mitochondrial cascade hypothesis will continue to evolve and attract interest.
可行的阿尔茨海默病(AD)假说必须解释其与年龄的相关性、普遍性、与淀粉样前体蛋白、tau蛋白和载脂蛋白E生物学的关联、与血管、炎症和胰岛素信号变化的联系以及全身特征。线粒体及受线粒体影响的参数可能将这些不同特征联系起来。线粒体生物学可引发与AD相关通路的变化,并介导产生临床表型的功能障碍。基于这些原因,构建线粒体级联假说的过程很简单,数十年来积累的数据也证明了其原理的有效性。其他AD假说可能也能解释与线粒体相关的现象,但如果未能做到这一点,原发性线粒体级联假说将继续发展并吸引关注。